Daniel Figeys

Daniel Figeys is a Professor in Biomedicine and Director at the Quadram Institute, affiliated with the University of East Anglia (UEA) through the Norwich Medical School, where he is a member of the Metabolic Health research group. He is actively accepting PhD students and leading cutting-edge research in microbiome and metaproteomics.

His research interests lie at the intersection of microbiology, biomedicine, and analytical chemistry, with a strong focus on the human gut microbiome, metaproteomics, and precision nutrition. He investigates how dietary components like polyphenols interact with gut microbes to influence metabolic health, and develops advanced mass spectrometry-based tools for clinical microbiome analysis.

The recent articles highlight a strong trend in developing and applying metaproteomic methodologies to understand host-microbe interactions in health and disease, including aging and viral infections like SARS-CoV-2. His work integrates meta-omics approaches to uncover functional changes in microbial communities and their impact on human physiology.

While no specific scientific awards are listed in the provided text, his leadership roles and publication record in top-tier journals reflect significant recognition in the field.

Daniel Figeys is actively involved in mentoring and research supervision, as evidenced by his openness to PhD students and collaborative publications. His work is supported by major research initiatives, likely involving substantial grants, though specific funding sources are not detailed. He leads a dynamic research environment focused on innovation in microbiome science.

He is central to the research ecosystem at the Quadram Institute, a world-leading center for gut health, microbiology, and food innovation. His leadership as Director and CEO of Quadram Institute Bioscience underscores his role in shaping interdisciplinary research teams and driving translational science in metabolic and microbial health.